D-0443-2024 Class III Terminated
Recall Details
- Product Type
- Drugs
- Report Date
- April 24, 2024
- Initiation Date
- March 25, 2024
- Termination Date
- July 16, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1,003 bottles
Product Description
Digoxin Tablets, USP 62.5 mcg (0.0625 mg), 100-count bottles, Rx Only, Manufactured by: Novitium Pharma LLC, 70 Lake Drive, East Windsor, New Jersey 08520, NDC 70954-200-10
Reason for Recall
Failed Impurities/Degradation Specifications
Distribution Pattern
U.S. Nationwide
Code Information
Lot M23011A; Exp. 12/2024